Cargando…
Safety and immunogenicity of a new glycoengineered vaccine against Acinetobacter baumannii in mice
Acinetobacter baumannii poses a serious threat to human health, mainly because of its widespread distribution and severe drug resistance. However, no licensed vaccines exist for this pathogen. In this study, we created a conjugate vaccine against A. baumannii by introducing an O‐linked glycosylation...
Autores principales: | Li, Xin, Pan, Chao, Liu, Zhicheng, Sun, Peng, Hua, Xiaoting, Feng, Erling, Yu, Yunsong, Wu, Jun, Zhu, Li, Wang, Hengliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8867989/ https://www.ncbi.nlm.nih.gov/pubmed/33755314 http://dx.doi.org/10.1111/1751-7915.13770 |
Ejemplares similares
-
A Short Peptide of Autotransporter Ata Is a Promising Protective Antigen for Vaccination Against Acinetobacter baumannii
por: Sun, Peng, et al.
Publicado: (2022) -
Resistance mechanisms of tigecycline in Acinetobacter baumannii
por: Sun, Chunli, et al.
Publicado: (2023) -
The Effect of Colistin Resistance-Associated Mutations on the Fitness of Acinetobacter baumannii
por: Mu, Xinli, et al.
Publicado: (2016) -
Safety and Prophylactic Efficacy of Liposome-Based Vaccine against the Drug-Resistant Acinetobacter baumannii in Mice
por: Khan, Masood Alam, et al.
Publicado: (2022) -
Colistin Resistance in Acinetobacter baumannii MDR-ZJ06 Revealed by a Multiomics Approach
por: Hua, Xiaoting, et al.
Publicado: (2017)